Novag Rino (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Novag Rino, is a alpha-adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with rhinitis and other upper‑respiratory conditions. GNH USA supplies Novag Rino as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride acts on the nasal mucosa to reduce swelling and improve airflow, making it useful for several common nasal conditions.

Nasal congestion: provides rapid relief of blocked nasal passages by constricting dilated blood vessels. Allergic rhinitis: alleviates nasal blockage associated with seasonal or perennial allergies. Non‑allergic rhinitis: improves airflow in patients with irritant‑induced nasal congestion.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Bitter taste - Minor nosebleeds (epistaxis)

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Elevated blood pressure or hypertension - Rapid heart rate (tachycardia) or arrhythmia - Severe allergic reaction (anaphylaxis) - Persistent nasal ulceration

Before using Oxymetazoline Hydrochloride, consider the following safety measures.

Pregnancy: consult a healthcare provider before use. Breastfeeding: discuss potential risks with a physician. Age restrictions: not recommended for children under 6 years. Concurrent nasal surgery or trauma: avoid use until healed. Drug interactions: inform the prescriber of other nasal decongestants or sympathomimetic agents. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with certain medications; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other topical nasal decongestants: may cause excessive vasoconstriction. - Systemic sympathomimetics (e.g., pseudoephedrine): increased cardiovascular effects.

Moderate Interactions (Monitor Closely):\n- Antihypertensive drugs: monitor blood pressure for additive effects. - Beta‑blockers: possible attenuation of cardiovascular response. - Tricyclic antidepressants: potential additive sympathomimetic activity.